Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Tax Withholding of 4,902 RGNX shares, $45.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | REGENXBIO Inc. (RGNX) | Tax Withholding | 4,902 | $45.7K |
| May 7, 2026 | Avalo Therapeutics, Inc. (AVTX) | Sale | 3,167 | $72.5K |
| Mar 31, 2026 | Avalo Therapeutics, Inc. (AVTX) | Exercise/Conversion | 3,166 | n/a |
| Jan 8, 2026 | REGENXBIO Inc. (RGNX) | Grant/Award | 73,749 | n/a |
| Sep 3, 2025 | REGENXBIO Inc. (RGNX) | Tax Withholding | 4,901 | $43.8K |
| Jun 18, 2025 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 20,100 | n/a |
| Apr 2, 2025 | Avalo Therapeutics, Inc. (AVTX) | Exercise/Conversion | 3,167 | n/a |
| Jan 6, 2025 | REGENXBIO Inc. (RGNX) | Grant/Award | 62,547 | n/a |
| Sep 18, 2024 | REGENXBIO Inc. (RGNX) | Grant/Award | 58,869 | n/a |
| Aug 14, 2024 | Avalo Therapeutics, Inc. (AVTX) | Grant/Award | 24,600 | n/a |